Utilization, cost, and outcome of branded vs compounded 17-alpha hydroxyprogesterone caproate in prevention of preterm birth. Fried*, I., Beam*, A. L, Kohane, I. S, & Palmer, N. P JAMA internal medicine, 177(11):1689–1690, American Medical Association, 2017. bibtex @article{fried2017utilization,
title={Utilization, cost, and outcome of branded vs compounded 17-alpha hydroxyprogesterone caproate in prevention of preterm birth},
author={Fried*, Inbar and Beam*, Andrew L and Kohane, Isaac S and Palmer, Nathan P},
journal={JAMA internal medicine},
volume={177},
number={11},
pages={1689--1690},
year={2017},
keywords={Healthcare},
publisher={American Medical Association}
}
Downloads: 0
{"_id":"ggpuszk7KqHPxMAXa","bibbaseid":"fried-beam-kohane-palmer-utilizationcostandoutcomeofbrandedvscompounded17alphahydroxyprogesteronecaproateinpreventionofpretermbirth-2017","authorIDs":[],"author_short":["Fried*, I.","Beam*, A. L","Kohane, I. S","Palmer, N. P"],"bibdata":{"bibtype":"article","type":"article","title":"Utilization, cost, and outcome of branded vs compounded 17-alpha hydroxyprogesterone caproate in prevention of preterm birth","author":[{"propositions":[],"lastnames":["Fried*"],"firstnames":["Inbar"],"suffixes":[]},{"propositions":[],"lastnames":["Beam*"],"firstnames":["Andrew","L"],"suffixes":[]},{"propositions":[],"lastnames":["Kohane"],"firstnames":["Isaac","S"],"suffixes":[]},{"propositions":[],"lastnames":["Palmer"],"firstnames":["Nathan","P"],"suffixes":[]}],"journal":"JAMA internal medicine","volume":"177","number":"11","pages":"1689–1690","year":"2017","keywords":"Healthcare","publisher":"American Medical Association","bibtex":"@article{fried2017utilization,\n title={Utilization, cost, and outcome of branded vs compounded 17-alpha hydroxyprogesterone caproate in prevention of preterm birth},\n author={Fried*, Inbar and Beam*, Andrew L and Kohane, Isaac S and Palmer, Nathan P},\n journal={JAMA internal medicine},\n volume={177},\n number={11},\n pages={1689--1690},\n year={2017},\n keywords={Healthcare},\n publisher={American Medical Association}\n}\n\n","author_short":["Fried*, I.","Beam*, A. L","Kohane, I. S","Palmer, N. P"],"key":"fried2017utilization","id":"fried2017utilization","bibbaseid":"fried-beam-kohane-palmer-utilizationcostandoutcomeofbrandedvscompounded17alphahydroxyprogesteronecaproateinpreventionofpretermbirth-2017","role":"author","urls":{},"keyword":["Healthcare"],"metadata":{"authorlinks":{}},"downloads":0,"html":""},"bibtype":"article","biburl":"https://www.dropbox.com/s/0k6pa735xx3gr9i/citations.txt?dl=1","creationDate":"2019-07-24T12:46:58.180Z","downloads":0,"keywords":["healthcare"],"search_terms":["utilization","cost","outcome","branded","compounded","alpha","hydroxyprogesterone","caproate","prevention","preterm","birth","fried*","beam*","kohane","palmer"],"title":"Utilization, cost, and outcome of branded vs compounded 17-alpha hydroxyprogesterone caproate in prevention of preterm birth","year":2017,"dataSources":["2LQLmS62hSLmYBK2a","R7XXNLtmcExJiuMoA"]}